These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11679130)

  • 41. Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire.
    Utzinger J; N'Goran EK; Esse Aya CM; Acka Adjoua C; Lohourignon KL; Tanner M; Lengeler C
    Trop Med Int Health; 1998 Sep; 3(9):711-20. PubMed ID: 9754666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire.
    Raso G; N'Goran EK; Toty A; Luginbühl A; Adjoua CA; Tian-Bi NT; Bogoch II; Vounatsou P; Tanner M; Utzinger J
    Trans R Soc Trop Med Hyg; 2004 Jan; 98(1):18-27. PubMed ID: 14702835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe.
    Midzi N; Sangweme D; Zinyowera S; Mapingure MP; Brouwer KC; Kumar N; Mutapi F; Woelk G; Mduluza T
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):759-66. PubMed ID: 18486169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the Clinitek®, a point-of-care urinalysis system for the measurement of clinically significant urinary metabolites and detection of haematuria in Schistosoma haematobium infected children in southern Côte d'Ivoire.
    Panic G; Barda B; Kovač J; Coulibaly JT; Keiser J
    Parasit Vectors; 2019 Jun; 12(1):298. PubMed ID: 31196145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.
    Coulibaly JT; Panic G; Yapi RB; Kovač J; Barda B; N'Gbesso YK; Hattendorf J; Keiser J
    BMC Med; 2018 Jun; 16(1):81. PubMed ID: 29855373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parasitological Observation in Schoolchildren with Urogenital Schistosomiasis Following Treatment with Three Different Brands of Praziquantel.
    Jin Y; Cha S; Lee J; Elhag MS; Hong ST; Lee YH
    J Korean Med Sci; 2020 Nov; 35(46):e394. PubMed ID: 33258330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
    Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of dipsticks in Schistosoma haematobium infections in four villages in the middle valley of the Senegal River Basin, Senegal.
    Shaw DJ; Picquet M; Ly A; Sambou B; Vercruysse J
    Trans R Soc Trop Med Hyg; 1998; 92(6):634-5. PubMed ID: 10326107
    [No Abstract]   [Full Text] [Related]  

  • 49. Epidemiology of schistosomiasis in two high-risk communities of south Cote d'Ivoire with particular emphasis on pre-school-aged children.
    Coulibaly JT; N'Gbesso YK; N'Guessan NA; Winkler MS; Utzinger J; N'Goran EK
    Am J Trop Med Hyg; 2013 Jul; 89(1):32-41. PubMed ID: 23690549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiological profile of the schistosomiasis in school children in the Agneby Region (south-east of Côte-d'Ivoire)].
    Adoubryn KD; Ouhon J; Yapo CG; Assoumou EY; Ago KM; Assoumou A
    Bull Soc Pathol Exot; 2006 Mar; 99(1):28-31. PubMed ID: 16568679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of cure by detection of circulating antigens in serum and urine, following schistosomiasis mass treatment in two villages of the Office du Niger, Mali.
    De Clercq D; Sacko M; Vercruysse J; vanden Bussche V; Landouré A; Diarra A; Gryseels B; Deelder A
    Acta Trop; 1997 Dec; 68(3):339-46. PubMed ID: 9492918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel.
    Ahmed AM; Abbas H; Mansour FA; Gasim GI; Adam I
    Parasit Vectors; 2012 Jun; 5():108. PubMed ID: 22676052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study.
    Kokaliaris C; Garba A; Matuska M; Bronzan RN; Colley DG; Dorkenoo AM; Ekpo UF; Fleming FM; French MD; Kabore A; Mbonigaba JB; Midzi N; Mwinzi PNM; N'Goran EK; Polo MR; Sacko M; Tchuem Tchuenté LA; Tukahebwa EM; Uvon PA; Yang G; Wiesner L; Zhang Y; Utzinger J; Vounatsou P
    Lancet Infect Dis; 2022 Jan; 22(1):136-149. PubMed ID: 34863336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy, safety, and palatability of arpraziquantel (L-praziquantel) orodispersible tablets in children aged 3 months to 6 years infected with Schistosoma in Côte d'Ivoire and Kenya: an open-label, partly randomised, phase 3 trial.
    N'Goran EK; Odiere MR; Assandé Aka R; Ouattara M; Aka NAD; Ogutu B; Rawago F; Bagchus WM; Bödding M; Kourany-Lefoll E; Tappert A; Yin X; Bezuidenhout D; Badenhorst H; Huber E; Dälken B; Haj-Ali Saflo O
    Lancet Infect Dis; 2023 Jul; 23(7):867-876. PubMed ID: 36893784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and Risk Factors for Schistosomiasis among Schoolchildren in two Settings of Côte d'Ivoire.
    Angora EK; Boissier J; Menan H; Rey O; Tuo K; Touré AO; Coulibaly JT; Méité A; Raso G; N'Goran EK; Utzinger J; Balmer O
    Trop Med Infect Dis; 2019 Jul; 4(3):. PubMed ID: 31340504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics and epidemiological profile of Buruli ulcer in the district of Tiassalé, south Côte d'Ivoire.
    N'krumah RTAS; Koné B; Cissé G; Tanner M; Utzinger J; Pluschke G; Tiembré I
    Acta Trop; 2017 Nov; 175():138-144. PubMed ID: 28034768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic community.
    Asuming-Brempong EK; Ayi I; van der Puije W; Gyan BA; Larbi IA; Ashong Y; Frempong NA; Quartey JK; Otchere J; Jones FM; Wilson S; Dunne DW; Boakye DA
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010115. PubMed ID: 35263327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel.
    Walker JW; Kittur N; Binder S; Castleman JD; Drake JM; Campbell CH; King CH; Colley DG
    Am J Trop Med Hyg; 2020 Feb; 102(2):328-338. PubMed ID: 31889506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study on the efficacy of praziquantel and albendazole in the treatment of urinary schistosomiasis in Adim, Cross River State, Nigeria.
    Ben SA; Useh MF
    Int Health; 2017 Sep; 9(5):288-293. PubMed ID: 28911129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.